IL-1β, IL-18 and ASC, the pivotal elements of the inflammatory signaling pathway, are upregulated in breast cancer cells (77), but the specific cancer-promoting mechanism of NLRP1 inflammasomes needs to be further verified. Here, NLRP1 is linked to breast carcinoma.